Cases & Deals

ToolGen defends revolutionary CRISPR technology patent

Clients ToolGen, Inc.

Jones Day is acting for ToolGen, Inc. in relation to a challenge to its patent rights concerning CRISPR, a technology that has revolutionized the field of molecular biology including gene editing in the medical, biotechnology, and agricultural and farming industries.

Grant Fisher v. ToolGen Incorporated [2018] APO 65